Lifileucel for previously treated unresectable or metastatic melanoma [ID3863]
In development
Reference number: GID-TA10752
Expected publication date:
Following the changes to remove technical engagement as standard from appraisal timelines, the timelines for the appraisal of Lifileucel for previously treated unresectable or metastatic melanoma have been revised. It is anticipated that the appraisal will begin in late-May 2024 when we will write to you about how you can get involved.